Inactivation of PI3K-C2α deregulates cell death pathways and sensitizes to endotoxic shock
Abstract
The organismal roles of the class II PI3K isoform PI3K-C2α remain poorly understood. Recent studies have found PI3K-C2α to promote arterial thrombosis and breast cancer metastasis, generating interest in this kinase as a drug target, with small molecule PI3K-C2α inhibitors now available. However, the consequences of systemic PI3K-C2α inactivation in the nondiseased, postnatal state are largely unknown. Here, we show that induction of genetic PI3K-C2α inactivation in adult mice is well tolerated, without adverse effects on normal physiology. Surprisingly, however, mice with inactive PI3K-C2α display strong sensitization to challenge with bacterial lipopolysaccharide (LPS), a model of endotoxic shock. This sensitization is recapitulated by vascular endothelial-specific deletion of PI3K-C2α. Furthermore, sensitization to LPS can be fully rescued by disabling extrinsic induction of cell death by combined caspase-8- and RIPK3 deficiency. These observations validate the tolerability of systemic PI3K-C2α inhibition in principle but reveal an unexpected role for PI3K-C2α in the regulation of extrinsic cell death pathways.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
York Posor
Department of Oncology, University College London (UCL) Cancer Institute, University College London
Sarah E. Conduit
Wayne Pearce
Department of Oncology, University College London (UCL) Cancer Institute, University College London
Daniele Morelli
Department of Oncology, University College London (UCL) Cancer Institute, University College London
Georgia Constantinou
Department of Oncology, University College London (UCL) Cancer Institute, University College London
Maria Whitehead
Department of Oncology, University College London (UCL) Cancer Institute, University College London
Neil J. Sebire
National Institute for Health and Care Research Great Ormond Street Hospital (NIHR GOSH) Biomedical Research Centre at
Cheryl L. Scudamore
Exepathology
Nieves Peltzer
Center for Molecular Medicine Cologne, University of Cologne
Henning Walczak
Bart Vanhaesebroeck